Ingenieurwissenschaften und zugeordnete Tätigkeiten
Filtern
Erscheinungsjahr
- 2023 (2)
Dokumenttyp
- Vortrag (1)
- Posterpräsentation (1)
Sprache
- Englisch (2)
Referierte Publikation
- nein (2)
Schlagworte
- Large-scale production (2) (entfernen)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (1)
We report the scale-up of a batch solid synthesis of zeolitic imidazolate framework-8 (ZIF-8) for reactive extrusion. The crystalline product forms in the extruder directly under the mixture of solid 2-methylimidazole and basic zinc carbonate in the presence of a catalytic amount of liquid. The process parameters such as temperature, liquid type, feeding rate, and linker excess were optimized using the setup specifically designed for in situ Raman spectroscopy. Highly crystalline ZIF-8 with a Brunauer–Emmett–Teller (BET) surface area of 1816 m2 g–1 was quantitatively prepared at mild temperature using a catalytic amount of ethanol and a small excess of the linker. Finally, we developed a simple and comprehensive approach to evaluating the environmental friendliness and scalability of metal–organic framework (MOF) syntheses in view of their large-scale production.
Metal-organic framework-based biocomposites (MOF-biocomposites) are promising materials for biosensing, biocatalysis, and delivery of biopharmaceuticals. One of the most studied MOFs for bioapplications is ZIF-8 (zeolitic imidazolate framework 8) due to its high surface area, high thermal and chemical stability, and low cytotoxicity. The conventional synthesis of ZIF-8-biocomposites called biomimetic mineralization includes mixing selected biomolecules 2-methylimidazole, and soluble Zn2+ source in water.[3] Despite the high efficiency of the method, it does not allow for large-scale production and is restricted to hydrophilic biomolecules. Aimed at developing a scalable and versatile approach, we adapted our recently-reported ZIF-8 reactive extrusion for biocomposite production.
We selected bovine serum albumin (BSA) as an inexpensive model biomacromolecule for the preparation of biocomposites. The synthesis of BSA@ZIF-8 was performed using a twin-screw extruder ZE 12 HMI (Three-Tec Gmbh) at a mild temperature of 40 °C. Automatic volumetric feeder ZD 12B (Three-Tec GmbH) was used to supply the reagent mixture consisting of 2-methylimidazole, zinc source, and BSA. To initiate the reaction, a catalytic amount of EtOH was added using a peristaltic pump BT-L (Lead Fluid, China). Powder X-Ray diffraction (PXRD), thermogravimetric analysis (TGA), FTIR, and N2 adsorption were used to characterize the extrudates.
Highly crystalline and pure BSA@ZIF-8 with different BSA loadings was isolated after washing the extrudate with EtOH and sodium dodecyl sulfate. The EtOH feeding rate was optimized by following the protein encapsulation efficiency at a BSA mass fraction of 10%. A continuous extruder operation under optimized conditions showed good reproducibility and capability of producing biocomposites on the kilograms scale. These results provide highly valuable information for cheap and large-scale production of ZIF-8-based biocomposites. Due to the lack of restrictions on molecule size and solubility, our proof-of-concept study may significantly expand the selection of biomolecules for immobilization in ZIF-8, making the method applicable to various functional applications